Nonalcoholic fatty liver disease: pathology and pathogenesis

Area of Science:

• Hepatology
• Metabolic Diseases
• Gastroenterology

Background:

• Nonalcoholic fatty liver disease (NAFLD) is the primary cause of chronic liver disease in pediatric and adult populations.
• NAFLD spectrum includes steatosis, steatohepatitis, and fibrosis, potentially progressing to cirrhosis and hepatocellular carcinoma.
• NAFLD is strongly associated with obesity and insulin resistance, with dietary factors like high saturated fat and fructose intake playing a significant role.

Purpose of the Study:

• To elucidate the complex pathophysiology of nonalcoholic fatty liver disease (NAFLD).
• To explore the roles of diet, obesity, insulin resistance, and cellular mechanisms in NAFLD development.
• To highlight the association between visceral adipose tissue dysfunction and liver injury in NAFLD.

Main Methods:

• Review of histologic findings to understand NAFLD pathophysiology.
• Analysis of the association between NAFLD, obesity, and insulin resistance.
• Investigation into mechanisms of triglyceride accumulation in hepatocytes.
• Examination of cytokine expression in visceral adipose tissue dysfunction.
• Consideration of cellular stress and the endocannabinoid system in NAFLD.

Main Results:

• NAFLD encompasses a range of liver conditions from simple steatosis to advanced fibrosis.
• Excess triglyceride accumulation in hepatocytes is a key feature of NAFLD.
• Obesity, insulin resistance, and Western diet contribute significantly to NAFLD pathogenesis.
• Aberrant cytokine expression from dysfunctional visceral adipose tissue impacts liver injury.
• Cellular stress and the endocannabinoid system are implicated in NAFLD.

Conclusions:

• NAFLD is a complex condition driven by metabolic dysfunction, diet, and cellular processes.
• Understanding the interplay of these factors is crucial for effective NAFLD management.
• Further research into cellular stress and the endocannabinoid system may offer new therapeutic targets.